Archive for March, 2012

Share via email

Danie Roy

The Supreme Court finally ruled that the Prometheus Labs patents in Mayo v Prometheus are invalid.  I personally tip my hat to the court on this decision.  I’ve written about this case before, and I’ve done some general Pharamaceutically Speaking analysis on how 101 applies to pharma and personalized medicine. Because Prometheus was originally a 101 issue, we’ll start there.

As I said before in my Invention vs Observation article, some inventive step MUST be included. Simply observing a law of nature isn’t patentable. In this case, testing apparatus and SPECIFIC tests might be patentable. If, for example, you invent a blood draw vial that gives a test result on receiving at least X amount of blood, THAT is patentable. If you invent a diagnostic machine learning algorithm that can determine the presence of a disease (a very specific test, which a human could otherwise not reasonably perform), then of course that would be patentable. But, in such a case, that necessarily means that “if the blood level of the drug (or protein produced in response to it) is outside of the range Y to Z, then we need to adjust” is NOT patentable… that is an observation.

Hope you're not afraid of needles...

The court then went on to see if other parts of the methods were patentable. My 103 analysis kicks in here: testing blood levels for the efficacy of immunosuppressant therapy drugs has been around for a VERY LONG TIME (known since 1988 at the very latest).  The parts that weren’t simple observation really were well known in the art. I’m no pharmacist or doctor, but if you ask anyone with an autoimmune disorder how often they have to go get their blood levels checked for whatever immunosuppressant they are on, you’re going to get an answer in the range of every week to every few months.

Perhaps, if the process were more involved than checking the level of the drug itself, such as checking levels of proteins or metabolites that could be produced by the presence of the drug, as well as taking into account other factors that might influence those levels, you might have a patentable, inventive process. Simply administering a drug and seeing how much is maintained in the body, however, isn’t particularly inventive.

Don’t believe me?  Let’s go through Claim 1.

A method of optimizing therapeutic efficacy for treatment of an immune-mediated gastrointestinal disorder, comprising:

Okay, we’ve established this is for treatment of an immune disorder.

(a) administering a drug providing 6-thioguanine to a subject having said immune-mediated gastrointesti­nal disorder; and

Administer a drug.

(b) determining the level of 6-thioguanine in said subject having said immune-mediated gastrointesti­nal disorder,

Check to see how much of the drug is in the person’s system.

wherein the level of 6-thioguanine less than about 230 pmol per 8×108 red blood cells indicates a need to increase the amount of said drug subsequently admin­istered to said subject and

We’re clarifying that we are checking the blood for a specific minimum level of the drug.

wherein the level of 6-thioguanine greater than about 400 pmol per 8×108 red blood cells indicates a need to decrease the amount of said drug subsequently administered to said subject.

…and checking the blood for a specific maximum level of the drug.

That’s Claim 1. It’s…shockingly basic. And, while it can be considered personalized medicine, the field of personalized medicine shouldn’t be too horribly affected. After all, drugs and tools are still patentable… simple correlations, or correlation observations, on the other hand, are (and rightly should be) out of the question.

Share via email

By Daniel Davidson

Dr. Dre is not a new comer to fighting in courts for his intellectual property.  Around this time last year, a judge awarded Dre 100 percent of the online sales of his iconic compilation, The Chronic.  In a recent letter sent to up-and-coming music producer, DIAMONDDre, the Dr. tells him to lose the name.

DIAMONDDre was granted a Certificate of Registration from the U.S. Patent and Trademark Office on December 6, 2011 for his moniker.  Also a holder of a U.S. Trademark Registration, you guessed it, Andre Young, p/k/a Dr. Dre.  In fact, the two service marks are registered in International Class 41 for entertainment services (tisk, tisk Examining Attorney).

In the letter issued to DIAMONDre, Dr. Dre demands that DIAMONDDre cease and desist any further use of the name, or he will pursue his rights in a court of law.  Would Dr. Dre have a case?  I would think so.  I am even surprised that a likelihood of confusion refusal wasn’t issued by the Examining Attorney of DIAMONDDre’s trademark application.

Nonetheless, I am sure that Dr. Dre has given DIAMONDDre a deadline in which to agree to comply with the cease and desist letter.  Should DIAMONDDre not comply with Dr, Dre’s demands, within the allotted time frame, it will be interesting to see if Dr. Dre will fight to remain the only Dre in the music production business.  The value that Dr. Dre’s name has obtained is worth millions, and I would have to assume that it would be worth it to Dr. Dre to uphold his exclusive right to use the name Dr. Dre in connection with entertainment services.  Is “DIAMONDRE” exactly the same as “Dr. Dre?”  Of course not, but it us confusingly similar, the standard for confusion in trademark law.

Cheers.

Share via email

I regularly get calls from clients who think they need a copyright when in fact they need a trademark (or even a patent!). The confusion is completely understandable, since other than intellectual property lawyers and those in related fields, our educational system simply doesn’t teach about intellectual property. In fact, my schooling on property didn’t go beyond “don’t take what’s not yours”. Let’s get the basics out of the way:

What’s a Copyright?

Copyright is protection for authors of “original works” including literary, dramatic, musical, artistic, and certain other intellectual works, both published and unpublished. Copyright owners have the exclusive right to reproduce the copyrighted work, to prepare derivative works, to distribute copies or phonorecords of the copyrighted work, to perform the copyrighted work publicly, or to display the copyrighted work publicly.

What’s a Trademark?

A trademark is a word, name, symbol or device used in trade with goods to indicate the source of the goods and to distinguish them from the goods of others. Trademarks protect the name, not the good or service itself. You can sell all the cola you want, but you can’t sell it as Coca-Cola, even though your beverage may be chemically identical. Therein lies the potential value of a trademark: the price difference between Chek Cola and Coke.

Copyright vs. Trademark

Copyrights protect authorship in tangible forms of expression, including: two and three-dimensional art, images, songs, music and sound recordings, written works, plays and other performance arts, and videos of performance arts.

Trademarks protect words, phrases and logos used in federally regulated commerce to identify the source of goods and/or services.

Copyright protects the form of expression rather than the subject matter of the writing. For example, if you copyright a description of a widget, you could prevent others from copying your description. You would not, however, be able to prevent others from writing a new description or from making (or using) the widget.

Sometimes both copyright and trademark protection are useful. For example, a new slogan for your widget may also appear in print ads for the widget. You will likely want both copyright and trademark protection, since they offer different protections for different things. The ad’s text and graphics are covered by copyright, but the slogan may be protected by trademark law. Cover your bases by getting both — your copyright will not protect a bare slogan, or trade name.

Additionally, registering a trademark is entirely different from registering a copyright. Copyrights are cheaper and generally easier to register, as opposed to trademarks, which require a longer and more adversarial, as opposed to ministerial, process.

Of course, copyrights come with mandatory licensing and royalty payments. Trademarks do not.

Lastly, the tests for infringement are quite different for copyright and trademarks (that’s a whole ‘nother article right there!).

Share via email

By Daniel Davidson

HAPPY ST. PATRICK’S DAY!!!  We here at Tactical IP are celebrating this year’s St. Patty’s Day in full force, and when I say “we” I can really only speak for myself.  The time is finally here.  The time I can actually be cool for having red hair, drinking a beer while writing this is not frowned upon, and wearing the same green shirt as you did last night is okay.  May the road rise to meet you, and may the wind be always at your back.  Here are some appropriate Irish day patents.

Patent No. 3,729,321 not only has the area code for Brevard County in it, but it also is titled “Preparation of Beer.”  Appropriate?  I think so.  Raise your glasses!

Next, we have a tool for a hell of a sport.  Why wouldn’t you need a shamrock bingo dobber?  Thank you Design Patent No. D 529,549 maker.  We can all have a little more style when we yell “BINOG!”

Well, I hear the Jameson bottle calling me so I’ll just give you one more.  May you have love that never ends, lots of money, and lots of friends.  Patent No. 2,369,721 helps me enjoy the nectar of the gods.  It’s a patent for a beer dispenser.

Everyone enjoy the best holiday in the world safely, and remember, if it wasn’t for the Irish, there would be no place to go (Tin Pan Alley, ‘If It Wasn’t For the Irish and the Jews‘).  CHEERS!

 

Share via email

By: Mark R. Malek

In this weeks episode of the question that I recently had to field at Zies Widerman & Malek is whether or not it is permissible to design around a patent.  The short answer is OF COURSE!  How else is there to be progress?  How else can inventions get improved?  This is the reason why people have come up with the better mouse trap, right – in other words, inventors have constantly improved that which came before them.  How else did we evolve from the original Apple computer to this tiny little MacBook Air that I am writing this article on while sitting inside of an airplane?

A simple “yes” to the question obviously is not enough.  How much is enough to design around a patent? How much do you have to change?  If I hear the “10% rule” one more time, I’m going to hunt down the crazy person that started it, and do some damage.  Where did that one come from?  I suspect it was on the “internet” and, therefore, it must be true.  There is no such thing as the 10% rule.  In case you are wondering, this is the rule that several clients have told me about and wanted to know how to calculate 10%.  The rule, apparently, is that all you have to do is change your invention by 10% in order to get around someone else’s patent.  I have also been informed that the same applies to copyright infringement.  Once and for all – THIS IS NOT TRUE.  Please do not expect an attorney to go to court with that argument.

When looking at a patent, go to the end.  You will notice a little section that is referred to as the claims.  The claims of a patent application can be described as the “property boundary” of the patent.  For a really good overview of patents, see Gene Quinn’s articles on IPWatchDog.com.  The claims are the way that the invention is defined in words.  The claims set forth the limitations of an invention, and defines the elements that make up the invention.  For example, suppose you have invented a widget.  The claims would indicate that the invention is a “widget that comprises elements A, B, C and D arranged in a particular way.”  Yes, this is an extraordinarily simplistic way of describing a claim, but it’ll make sense in a second.

If you ask your attorney to determine if your invention reads on the claims of a patent, or if you have successfully defined around the claims of the patent, your patent attorney should set up a claims chart.  The claims chart will likely break down the claims in a spreadsheet and try to analyze whether or not your invention includes each and every single element that is listed in the claim for the widget.  If your invention is a widget that also includes elements A, B, C and D, arranged in the same way as in the claims of the patent, then you have not designed around it.  Suppose, for example, you have replaced element C with element E?  Now you are probably onto something.  The analysis should not conclude there.  You should continue the analysis to make sure that element C cannot be read broadly enough to include element E.  This can usually be found in the specification, i.e., the rest of the patent.  If there is a sentence in there somewhere that reads something like “those skilled in the art will appreciate that element C is meant to include element E” then you probably have not done enough.

Obviously, I can write about this topic forever, but I promise to put up some follow up articles on designing around a patent – also known as reverse engineering.  In short, I hope that you take the following away from this article: It is permissible to design around a patent, but the process is not a simple one.  Be very careful in what you are doing and how you are defining your invention.


Subscribe

Login



TUESDAY, MAY 21, 2013

Bad Behavior has blocked 11285 access attempts in the last 7 days.